May 14, 2024 Arcutis First Quarter 2024 Financial Results & Business Update February 27, 2024 Arcutis Fourth Quarter 2023 Financial Results & Business Update January 22, 2024 Arcutis Biotherapeutics ZORYVE (roflumilast) Foam Presentation December 15, 2023 Arcutis ZORYVE Foam FDA Approval Presentation November 3, 2023 Arcutis Third Quarter 2023 Financial Results & Business Update October 19, 2023 ARQT October 2023 Corporate Overview September 19, 2023 Arcutis Biotherapeutics Provides Positive Atopic Dermatitis Program Updates Presentation August 8, 2023 Arcutis Second Quarter 2023 Financial Results & Business Update December 12, 2022 Arcutis BioTherapeutics Phase 3 Atopic Dermatitis Topline Data Presentation August 1, 2022 Arcutis ZORYVE FDA Approval Presentation Current page 1 Page 2 Next page next › Last page last »
September 19, 2023 Arcutis Biotherapeutics Provides Positive Atopic Dermatitis Program Updates Presentation